Collector
Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles | Collector
Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles
The Japan Times

Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles

The move comes as COVID vaccine ‌makers grapple ‌with pushback from the U.S. administration and weak U.S. demand for the shots.

Go to News Site